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Introduction: Acute elevations of biomarkers reflecting myocardial injury, thrombosis, systemic in-
flammation, and heart dysfunction are associated with poor prognosis among hospitalized patients 
with COVID-19.1-3 In this study, we aimed to determine levels of these biomarkers in patients that were 
hospitalized with COVID-19 pneumonia at our institution during the first pandemic wave. Secondly, 
we aimed to determine if these biomarkers correlate with risk assessment tools such as MEWS (Modi-
fied Early Warning Score) and SOFA (Sequential Organ Failure Assessment) scores that reflect disease 
severity and clinical deterioration of patients. 
Patients and Methods: Data of 40 consecutive hospitalized patients with PCR-confirmed SARS-CoV-2 
infection and pneumonia verified by imaging methods were considered for the analysis. 
Results: The mean age was 80.5 ± 9.9 years and 25 (78.1%) were women. Of these patients, 9 (22.5%) had 
a significant renal insufficiency (eGFR <44 mL/min./1.73 m2) and were excluded from the analysis. Of 
the remaining 31 patients, 17 (54.8%) had laboratory evidence of myocardial injury (high sensitivity 
cardiac troponin T – hs-cTnT >14 pg/mL) while 10 patients (32.3%) satisfied acute heart failure rule-in 
criteria according to natriuretic peptide cut-off values adjusted for age. The mean hs-cTnT value was 
Figure 1. Prevalence of abnormal cardiovascular biomarkers reflecting myocardi-
al injury, ventricular overload, systemic inflammation and thrombotic risk among 
patients hospitalized with COVID-19 pneumonia.
CRP - C-reactive protein; hs-cTnT - high-sensitivity cardiac troponin T; NT-proBNP - N-terminal 
of proBrain Natriuretic Peptide
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TABLe 1.Correlation of cardiovascular laboratory parameters with the risk of clinical deterioration (MEWS score) and estimated rate 
of organ failure (SOfA score).
Laboratory parameter MEWS score SOFA score
r-value p-value r-value p-value
NT-proBNP 0.360 0.047* 0.360 0.047*
hs-cTnT 0.304 0.096 0.306 0.094
CRP 0.802 <0.001* 0.710 <0.001*
D-dimer 0.449 0.011* 0.439 0.013*
CRP-C-reactive protein; hs-cTnT-high-sensitivity cardiac troponin T; MEWS-Modified Early Warning Score for Clinical Deterioration; NT-proBNP-N-terminal of proBrain 
Natriuretic Peptide; SOFA-sequential organ failure assessment score
*denotes significant result at p<0.05; r-Pearson’s correlation coefficient; 
p-statistical significance
28.9 ± 42.7 pg/mL while mean NT-proBNP value was 2481 ± 4662 pg/mL. One-third of patients (32.3%) had C-reactive protein values 
>41.1 mg/L (mean 33.7 ± 39.1 mg/L), highly predictive of severe disease. Nearly two-thirds of patients (N=19, 61.3%) had D-dimer levels 
>2.1 mg/L that was highly predictive of in-hospital death in previous studies (Figure 1). The mean MEWS and SOFA scores were 2.5 ± 
1.6 and 3.1 ± 2.3 points, respectively. In decreasing order of relationship, CRP, D-dimer, and NT-proBNP values significantly correlated 
with both MEWS and SOFA scores as shown in Table 1. Troponin values had a borderline association with both risk scores. 
Conclusions: Our data show that a significant number of patients hospitalized due to COVID-19 were elderly and with a high risk of 
thrombotic events and cardiac insufficiency. Likewise, a high inflammatory burden was observed in one-third of patients. CRP cor-
related the most with MEWS and SOFA score, followed by D-dimer levels and NT-proBNP while no significant interaction was observed 
with cardiac troponin values.
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